USA facts from all the RNS24 Jun 2020 16:57
Looking back through all the RNS this is what we know about the USA. So we are selling there but no sales figures are being released. All one of the RNS says is we are 13% on last year?
USA what do we know?
Mentioned in RNS
6/4/2020 “The Primerdesign COVID-19 test has received accreditation from a number of leading global regulatory authorities, including Public Health England and the US Food and Drug Administration.”
29/4/2020 “The Company continues to increase its sales level into the US market and is evaluating potential options to further expand its presence in this important market”.
14/5/2020 American sales were up 13% year-on-year driven by increased sales through Primerdesign’s key US customers
2/6/2020 Novacyt is also pleased with the progress it is making in the US market and expects to update the market in due course.
Job currently being advertised on Nova website
Job Summary Reporting to the Sales Director, Primerdesign Ltd, this role is responsible for sales and business development in the United States. The role will include direct sales, key account management, distributor and OEM account management, working within the Primerdesign Strategic Management Team to drive significant growth in the region
As National Manager, your communication and negotiation skills with market stakeholders are key, you will be expected to identify and create new agreements, identify the most profitable and sustainable markets, develop strategies to enter them and ensure that you are gaining the highest amount of revenue for the business.
Can't see anything else but this is defiantly a piece of the puzzle that is missing. As we don't know what the figures are this isnt IMHO wriiten into the current sp.
regards
Bramley1967
ps still a 1 billion mcap £15 sp IMHO DYOR I know some of you think I am crazy but look through my old posts and join up the dots its coming